This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Metyrapone for Delirium Due to Cushing’s Syndrome Induced by Occult Ectopic Adrenocorticotropic Hormone Secretion

Toshiro Kawashima, MD, PhD; Mariko Oda, MD; Taisuke  Kuno, MD; Hiroshi Ueki, MD; Shigeto Yamada, MD, PhD; Akitaka Hisatomi, MD, PhD

Published: July 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Cushing’s syndrome secondary to ectopic adrenocorticotropic hormone (ACTH) syndrome is rare. Ectopic ACTHdependent Cushing’s syndrome is encountered in 2 forms, the classic overt ectopic ACTH syndrome and "occult" ectopic ACTH-secreting tumors.1 Occult ectopic ACTH-secreting tumors are often small, and their detection requires meticulous examination. Despite recent technological advances, including inferior petrosal sinus sampling and the corticotropin-releasing hormone (CRH) stimulation test, localization of the tumor remains difficult.1-3

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 65

Quick Links: Delirium , Neurologic and Neurocognitive

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...